Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,866 | 192,300 | 187,774 | 163,794 | 123,618 |
| Receivables | 487,339 | 478,735 | 440,109 | 430,016 | 422,335 |
| Inventories | 125,500 | 124,131 | 119,046 | 114,956 | 107,372 |
| Other current assets | 42,697 | 49,833 | 53,079 | 81,315 | 86,358 |
| TOTAL | $838,166 | $889,530 | $843,348 | $826,625 | $782,378 |
| Non-Current Assets | |||||
| PPE Net | 896,901 | 896,273 | 788,554 | 781,973 | 767,192 |
| Intangibles | 1,336,634 | 1,350,303 | 901,812 | 872,777 | 871,312 |
| Other Non-Current Assets | 724,956 | 729,777 | 467,289 | 448,547 | 445,036 |
| TOTAL | $2,958,491 | $2,976,353 | $2,157,655 | $2,103,297 | $2,083,540 |
| Total Assets | $3,796,657 | $3,865,883 | $3,001,003 | $2,929,922 | $2,865,918 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,651 | 31,346 | 3,137 | 30,998 | 27,090 |
| Accounts payable and accrued liabilities | 77,736 | 67,481 | 73,479 | 77,838 | 66,232 |
| Accrued Expenses | 222,541 | 215,317 | 167,766 | 190,824 | 178,185 |
| Other current liabilities | 66,911 | 73,603 | 62,572 | 44,460 | 33,614 |
| TOTAL | $539,599 | $518,140 | $407,098 | $463,504 | $415,755 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,652,733 | 1,796,451 | 1,129,581 | 1,114,105 | 1,155,998 |
| Deferred Revenues | 140,760 | 130,393 | 98,473 | 117,569 | 108,984 |
| Other Non-Current Liabilities | 201,751 | 212,632 | 225,056 | 214,584 | 187,192 |
| TOTAL | $2,000,349 | $2,162,538 | $1,451,288 | $1,419,011 | $1,425,454 |
| Total Liabilities | $2,539,948 | $2,680,678 | $1,858,386 | $1,882,515 | $1,841,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,096 | 48,032 | 47,912 | 47,429 | 47,362 |
| Common Shares | 883 | 882 | 881 | 875 | 874 |
| Retained earnings | 460,120 | 399,752 | 346,044 | 288,658 | 318,507 |
| Other shareholders' equity | -155,550 | -149,951 | -122,129 | -142,318 | -180,023 |
| TOTAL | $1,256,709 | $1,185,205 | $1,142,617 | $1,047,407 | $1,024,709 |
| Total Liabilities And Equity | $3,796,657 | $3,865,883 | $3,001,003 | $2,929,922 | $2,865,918 |